血素在血液相关疾病中的双边功能:从基本机制到临床应用
Yijin Li1, Renyu Chen1, Chaofan Wang1
1Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
血素 (HPX) 对于对抗血溶性疾病中的血毒性至关重要. 这篇评论探讨了HPX和HPXX.
科学领域:
- 血液学 血液学 血液学
- 生物化学 生物化学
- 病理生理学 病理生理学
背景情况:
- 在血液溶解过程中释放的血红素驱动疾病的进展.
- 血素 (HPX) 中和有毒的血液.
- 内源HPX在严重的溶血条件下往往不足.
研究的目的:
- 审查HPX在血液病进展和预后中的作用.
- 探索基于HPX的治疗方法,治疗血质过载障碍.
- 讨论HPX生产和治疗策略的进展.
主要方法:
- 对HPX的功能和临床相关性的文献综述.
- 在血液溶解性疾病中分析HPX度变化.
- 评估涉及HPX补充和修改的治疗策略.
主要成果:
- HPX度变化与疾病阶段相关,这表明生物标志物的潜力.
- 由于HPX不足,需要进行治疗干预.
- 包括补充和修改在内的HPX疗法显示出对血毒性有希望.
结论:
- 在血液学疾病中,HPX是控制血毒性的关键因素.
- 基于HPX的疗法为治疗血红素过载条件提供了一个有希望的方法.
- 对HPX生产和修改的进一步研究对于临床应用至关重要.
更多相关视频
09:38A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
Published on: February 14, 2017
09:19In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time
Published on: May 24, 2020
相关概念视频
Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Regulation of Hematopoietic Stem Cells
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
